Loading Events

« All Events

  • This event has passed.

Duke team part of new peer-reviewed publication which adds support for IGFBP7 as a therapeutic target in ALS.

September 13, 2025 All day

Duke team part of new peer-reviewed publication which adds support for IGFBP7 as a therapeutic target in ALS. 

This is the first target that came out of the “ALS Reversals” research!

You can read it free HERE